Kiplinger Special Report: Planning Business Costs for 2026

To help you understand what is going on in the economy and beyond, our highly experienced Kiplinger Letter team will keep you abreast of the latest developments and forecasts (Get a free issue of The Kiplinger Letter or subscribe). You’ll get all the latest news first by subscribing, but we publish many (but not all) of our forecasts a few days afterward online. Here’s the latest…

Business Outlook: Economic impacts

When it comes to the economy, expect moderate growth. GDP figures should grow 1.6% in 2026, versus 1.7% in 2025. Manufacturing will continue to be sluggish, and consumer spending will slow a bit. But recession fears will fade into the background. Look for the Federal Reserve to cut its short-term interest rate by 2.0 points between September 2025 and the end of 2026, from 4.25% to 2.25%.

As the Fed cuts, other short-term rates will fall, too: Short-term consumer lending, home equity lines of credit and interest earned on Treasury bills. Long-term rates will likely rise a bit, with 10-year Treasury notes fluctuating around 4.5%. 30-year mortgage rates will be around 7% or a bit less. The unemployment rate will end 2026 at 4.5%, up slightly from 4.3% this year.

It’s likely inflation will stay stubborn, only getting down to 3.0% by the end of 2026, from 3.4% at the end of 2025. Tariffs will be more predictable next year, but businesses will still have to choose to absorb the cost or pass it on to customers. Tariffs will add about 15% to the cost of most imports, on average, this year; much more for some raw materials. 2026 tariffs are likely to target specific products or industries.

Corporate profits will rise 10% in 2026, a similar increase to 2025. Pay hikes figure to run 3.5%, similar to 2025, and close to the normal rate. Small businesses will see average wage hikes of 4.0%. Total benefit compensation will rise 3.8%, with an 8% rise in health insurance premiums. Prescription drugs are a big driver, with prices rising 3.4% and drug usage expanding. Spending on drugs will be up 8%, spurred by weight loss drugs, and gene and cell therapies.

Business Outlook: Energy costs

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top